✦ LIBER ✦

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

✍ Scribed by Michaela Diamant; Luc Van Gaal; Stephen Stranks; Justin Northrup; Dachuang Cao; Kristin Taylor; Michael Trautmann

Book ID: 117306407
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 496 KB
Volume: 375
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(10)60406-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of Once-Weekly Exena

Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks

✍ Diamant, M.; Van Gaal, L.; Stranks, S.; Guerci, B.; MacConell, L.; Haber, H.; Sc 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 740 KB

Insulin glargine versus sitagliptin in i

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial

✍ Pablo Aschner; Juliana Chan; David R Owens; Sylvie Picard; Edward Wang; Marie-Pa 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 277 KB

Insulin degludec, an ultra-long-acting b

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

✍ Bernard Zinman; Greg Fulcher; Paturi V Rao; Nihal Thomas; Lars A Endahl; Thue Jo 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 203 KB

Insulin degludec, an ultra-longacting ba

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

✍ Alan J Garber; Allen B King; Stefano Del Prato; Seamus Sreenan; Mustafa K Balci; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 284 KB

Comparison of insulin lispro protamine s

Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial

✍ V. Koivisto; S. Cleall; A. E. Pontiroli; D. Giugliano 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Once-daily basal insulin glargine versus

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

✍ Reinhard G Bretzel; Ulrike Nuber; Wolfgang Landgraf; David R Owens; Clare Bradle 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 172 KB